COMMUNIQUÉS West-GlobeNewswire

Olon Receives 2025 CMO Excellence in Green Chemistry Award
16/04/2025
RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry [...]
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES
16/04/2025
MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and [...]
Closest Things to Steroids 2025: Safe & Legal Substitute for Muscle Growth & Bodybuilding - Legal Alternatives By CrazyBulk USA
16/04/2025
Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- If you are under the pressure of losing weight and building lean muscle, legal steroid alternatives become a savior for you. They will offer you the same amount of [...]
Sabin Begins Marburg Vaccine Trial in U.S.
16/04/2025
WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in [...]
Best Oral Steroids 2025 - Bodybuilding Steroids for Muscle Growth, Strength & Huge Size - Bodybuilders' #1 Picks - By CrazyBulk USA
16/04/2025
Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- Oral anabolic steroids, or oral steroids, are artificial medications that are similar in action to the male sex hormone testosterone. Oral steroids are useful while [...]
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
16/04/2025
Live moderated webcast with members of the Senti Bio management team on Wednesday, April 23rd at 4:00 PM ET SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti [...]
Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
16/04/2025
AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's [...]
Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
16/04/2025
More than 25 Doheny Scientists and Clinician-Scientists to Present Posters, Papers and Mini symposia at Leading Eye Research Conference PASADENA, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of [...]
Biomerica Announces Reverse Stock Split
16/04/2025
Shares Expected to Begin Trading on Split-Adjusted Basis on April 21, 2025 IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products [...]
NeuroOne® Issues Letter to Shareholders
16/04/2025
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: [...]
Sienna Senior Living Completes Previously Announced Acquisition in Ottawa
16/04/2025
MARKHAM, Ontario, April 16, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a 165-suite [...]
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
16/04/2025
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges NEW YORK, [...]
Better Choice Sells Halo’s Business in Asia for $8.1 Million in Total Gross Proceeds Including $6.5 Million in Cash Up Front, the Equivalent of $3.34 Per Share
16/04/2025
Better Choice will retain ownership of its North American operations and rest-of-world ex-Asia operations TAMPA, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice [...]
Epilepsy Foundation of America Launches Comprehensive Epilepsy & Seizure Safe Classrooms Toolkit for K-12 Educators
16/04/2025
The Toolkit Fosters Safe and Inclusive Learning Environments for Students with Epilepsy BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy [...]
Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
16/04/2025
Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
16/04/2025
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
16/04/2025
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
16/04/2025
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company’s LIBERATE- [...]
Conduit Pharmaceuticals Announces Leadership Changes
16/04/2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (" Conduit Pharmaceuticals " or " Conduit " or the " Company ") today announced key leadership [...]

Pages